19 research outputs found
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine
Tryptophan catabolism is a major metabolic pathway utilized by several professional and non-professional antigen presenting cells to maintain immunological tolerance. Here we report that 3-hydroxy-l-kynurenamine (3-HKA) is a biogenic amine produced via an alternative pathway of tryptophan metabolism. In vitro, 3-HKA has an anti-inflammatory profile by inhibiting the IFN-gamma mediated STAT1/NF-kappa Beta pathway in both mouse and human dendritic cells (DCs) with a consequent decrease in the release of pro-inflammatory chemokines and cytokines, most notably TNF, IL-6, and IL12p70. 3-HKA has protective effects in an experimental mouse model of psoriasis by decreasing skin thickness, erythema, scaling and fissuring, reducing TNF, IL-1 beta, IFN-gamma, and IL-17 production, and inhibiting generation of effector CD8(+) T cells. Similarly, in a mouse model of nephrotoxic nephritis, besides reducing inflammatory cytokines, 3-HKA improves proteinuria and serum urea nitrogen, overall ameliorating immune-mediated glomerulonephritis and renal dysfunction. Overall, we propose that this biogenic amine is a crucial component of tryptophan-mediated immune tolerance. 3-hydroxy-L-kynurenamine (3-HKA) is a metabolite deriving from a lateral pathway of tryptophan catabolism. Here the authors identify 3-HKA as a biogenic amine and show it has anti-inflammatory properties that can protect mice against psoriasis and nephrotoxic nephritis.Peer reviewe
CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation
CX3CR1 expression is associated with the commitment of CSF-1R+ myeloid precursors to the macrophage/dendritic cell (DC) lineage. However, the relationship of the CSF-1R+ CX3CR1+ macrophage/DC precursor (MDP) with other DC precursors and the role of CX3CR1 in macrophage and DC development remain unclear. We show that MDPs give rise to conventional DCs (cDCs), plasmacytoid DCs (PDCs), and monocytes, including Gr1+ inflammatory monocytes that differentiate into TipDCs during infection. CX3CR1 deficiency selectively impairs the recruitment of blood Gr1+ monocytes in the spleen after transfer and during acute Listeria monocytogenes infection but does not affect the development of monocytes, cDCs, and PDCs
Recommended from our members
Abstract 3965: A cytolytic effector CD8+ T cell response is associated with remission in adult T-cell leukemia/lymphoma
Abstract Introduction: Adult T-cell leukemia/lymphoma (ATLL) is a rare blood cancer that develops in 3-5% of human T-lymphotropic virus-1 (HTLV1) carriers when the combination of viral oncoproteins and somatic mutations lead to malignant transformation of HTLV1 infected CD4+ T cells. ATLL has the worst overall survival among peripheral T cell lymphomas and remains a fatal disease despite efforts to improve outcomes over the last 35 years. First-line combination chemotherapy rarely achieves a durable response and two immune-modulating treatments (α-CCR4 and α-PD-1 monoclonal antibodies) failed in clinical trials. These findings highlight an urgent need to improve our understanding of the functional state of host immunity in ATLL patients. A host immune response against HTLV1 is pivotal in preventing ATLL development. Malignant ATLL cells can escape immune surveillance by preventing antigen presentation and engaging immune checkpoints. The prospect of an ATLL clone inducing systemic suppression was suggested in the literature but has not been directly examined. Furthermore, HTLV1-specific CD8+ cytotoxic T lymphocytes (CTLs) play an important role during viral latency, yet it remains unknown if they play a clinically relevant role during ATLL treatment. Methodology: In this work, we hypothesized that malignant ATLL cells will exhibit a suppressive immune phenotype and that effective therapeutic interventions will augment anti-ATLL CTLs to promote durable remission. We implemented an immune profiling approach to analyze PBMC samples from ATLL patients. Specifically, we developed a powerful 30-marker spectral flow panel to discriminate malignant ATLL cells from non-transformed lymphocytes (T, B, and NK cells) and monitor the expression of key transcription factors and markers associated with proliferation, cytolysis, and exhaustion. We analyzed diagnostic samples from the Montefiore-Einstein ATLL Biobank and samples collected during a phase 2 clinical trial aimed to assess the efficacy of a promising Belinostat/Zidovudine/Interferon-α combination therapy against ATLL (NCT02737046). Results: Our findings reveal that malignant ATLL cells exhibit an immune phenotype associated with robust immunosuppression and yet distinct from other suppressive immune cells (i.e., regulatory T cells). Additionally, we discovered that ATLL patient samples contained a unique population of phenotypically exhausted CD8+ T cells, the proportion of which was drastically reduced in patients under remission. Remarkably, a decrease in this exhausted subset correlated with the expansion of highly cytolytic CD8+ CTLs. Conclusion: Altogether, our findings suggest that ATLL cells may drive CD8+ CTLs into exhaustion to achieve immune evasion and that a robust anti-ATLL CTL response actively contributes to a remission state. Citation Format: Erik Guillen, Eric Liu, Yanhua Wang, Aditi Shastri, Alejandro Sica, Amit Verma, Xingxing Zhang, Juan Carlos Ramos, Hilda Ye, Gregoire Lauvau. A cytolytic effector CD8+ T cell response is associated with remission in adult T-cell leukemia/lymphoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3965
Profiling of Protein <i>O</i>‑GlcNAcylation in Murine CD8<sup>+</sup> Effector- and Memory-like T Cells
During
an acute infection, antigenic stimulation leads to activation,
expansion, and differentiation of naïve CD8<sup>+</sup> T cells,
first into cytotoxic effector cells and eventually into long-lived
memory cells. T cell antigen receptors (TCRs) detect antigens on antigen-presenting
cells (APCs) in the form of antigenic peptides bound to major histocompatibility
complex I (MHC-I)-encoded molecules and initiate TCR signal transduction
network. This process is mediated by phosphorylation of many intracellular
signaling proteins. Protein <i>O</i>-GlcNAc modification
is another post-translational modification involved in this process,
which often has either reciprocal or synergistic roles with phosphorylation.
In this study, using a chemoenzymatic glycan labeling technique and
proteomics analysis, we compared protein <i>O</i>-GlcNAcylation
of murine effector and memory-like CD8<sup>+</sup> T cells differentiated <i>in vitro</i>. By quantitative proteomics analysis, we identified
445 proteins that are significantly regulated in either effector-
or memory-like T cell subsets. Furthermore, qualitative and quantitative
analysis identified highly regulated protein clusters that suggest
involvement of this post-translational modification in specific cellular
processes. In effector-like T cells, protein <i>O</i>-GlcNAcylation
is heavily involved in transcriptional and translational processes
that drive fast effector T cells proliferation. During the formation
of memory-like T cells, protein <i>O</i>-GlcNAcylation is
involved in a more specific, perhaps more targeted regulation of transcription,
mRNA processing, and translation. Significantly, <i>O</i>-GlcNAc plays a critical role as part of the “histone code”
in both CD8<sup>+</sup> T cells subgroups
Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior.
International audienceThe cellular immune response to tissue damage and infection requires the recruitment of blood leukocytes. This process is mediated through a classical multistep mechanism, which involves transient rolling on the endothelium and recognition of inflammation followed by extravasation. We have shown, by direct examination of blood monocyte functions in vivo, that a subset of monocytes patrols healthy tissues through long-range crawling on the resting endothelium. This patrolling behavior depended on the integrin LFA-1 and the chemokine receptor CX(3)CR1 and was required for rapid tissue invasion at the site of an infection by this "resident" monocyte population, which initiated an early immune response and differentiated into macrophages
Profiling of Protein <i>O</i>‑GlcNAcylation in Murine CD8<sup>+</sup> Effector- and Memory-like T Cells
During
an acute infection, antigenic stimulation leads to activation,
expansion, and differentiation of naïve CD8<sup>+</sup> T cells,
first into cytotoxic effector cells and eventually into long-lived
memory cells. T cell antigen receptors (TCRs) detect antigens on antigen-presenting
cells (APCs) in the form of antigenic peptides bound to major histocompatibility
complex I (MHC-I)-encoded molecules and initiate TCR signal transduction
network. This process is mediated by phosphorylation of many intracellular
signaling proteins. Protein <i>O</i>-GlcNAc modification
is another post-translational modification involved in this process,
which often has either reciprocal or synergistic roles with phosphorylation.
In this study, using a chemoenzymatic glycan labeling technique and
proteomics analysis, we compared protein <i>O</i>-GlcNAcylation
of murine effector and memory-like CD8<sup>+</sup> T cells differentiated <i>in vitro</i>. By quantitative proteomics analysis, we identified
445 proteins that are significantly regulated in either effector-
or memory-like T cell subsets. Furthermore, qualitative and quantitative
analysis identified highly regulated protein clusters that suggest
involvement of this post-translational modification in specific cellular
processes. In effector-like T cells, protein <i>O</i>-GlcNAcylation
is heavily involved in transcriptional and translational processes
that drive fast effector T cells proliferation. During the formation
of memory-like T cells, protein <i>O</i>-GlcNAcylation is
involved in a more specific, perhaps more targeted regulation of transcription,
mRNA processing, and translation. Significantly, <i>O</i>-GlcNAc plays a critical role as part of the “histone code”
in both CD8<sup>+</sup> T cells subgroups